IL6 and neoplasm: Cluster 8 and cluster 12, which have high-risk scores and mostly appeared in the middle stages of LUAD (12w and 18w, Figures S6C–F), showed more cellular response (such as IL2, IL6), and the abilities were lost with tumor progression, which could be related to the tumor progression (Figure 7D).